Feasibility Study of Retinal Screening Using the RetinaVue 100 Camera in Outpatient Dialysis Centers
Completed · Not applicable
Conditions studied: Kidney Failure, Chronic, Eye Diseases, Diabetic Retinopathy
In brief
The purpose of this research study is to look at retinal abnormalities in outpatient renal dialysis patients using the FDA approved RetinaVue 100 hand-held (non-mydriatic) camera.
Key facts
- Study ID
- NCT02823600
- Run by
- University of North Carolina, Chapel Hill
- People needed
- 68
- Starts
- 2016-07-01
- Expected to finish
- 2017-05-01
- Last updated by the study team
- 2018-07-20
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- The subject must currently be seeking treatment for end-stage renal disease (ESRD) at one of the specified dialysis clinics.
- The subject must be ≥ 18 years of age.
You may not qualify if…
- The subject is <18 years of age.
- No exclusions will be made on the basis of gender, ethnicity, or race.
Where it is running
- UNC Ophthalmology — Chapel Hill, North Carolina, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.